High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head
Abstract Background Nontraumatic osteonecrosis of the femoral head (ONFH) is treated with a series of methods. High-energy extracorporeal shock wave therapy (ESWT) is an option with promising mid-term outcomes. The objective of this study was to determine the long-term outcomes of ESWT for ONFH. Met...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-02-01
|
| Series: | Journal of Orthopaedic Surgery and Research |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s13018-017-0705-x |
| _version_ | 1817992584066236416 |
|---|---|
| author | Kai Xie Yuanqing Mao Xinhua Qu Kerong Dai Qingwei Jia Zhenan Zhu Mengning Yan |
| author_facet | Kai Xie Yuanqing Mao Xinhua Qu Kerong Dai Qingwei Jia Zhenan Zhu Mengning Yan |
| author_sort | Kai Xie |
| collection | DOAJ |
| description | Abstract Background Nontraumatic osteonecrosis of the femoral head (ONFH) is treated with a series of methods. High-energy extracorporeal shock wave therapy (ESWT) is an option with promising mid-term outcomes. The objective of this study was to determine the long-term outcomes of ESWT for ONFH. Methods Fifty-three hips in 39 consecutive patients were treated with ESWT in our hospital between January 2005 and July 2006. Forty-four hips in 31 patients with stage I–III nontraumatic ONFH, according to the Association Research Circulation Osseous (ARCO) system, were reviewed in the current retrospective study. The visual analog pain scale (VAS), Harris hip score, radiography, and magnetic resonance imaging were used to estimate treatment results. The progression of ONFH was evaluated by imaging examination and clinical outcomes. The results were classified as clinical success (no progression of hip symptoms) and imaging success (no progression of stage or substage on radiography and MRI). Results The mean follow-up duration was 130.6 months (range, 121 to 138 months). The mean VAS decreased from 3.8 before ESWT to 2.2 points at the 10-year follow-up (p < 0.001). The mean Harris hip score improved from 77.4 before ESWT to 86.9 points at the 10-year follow-up. The clinical success rates were 87.5% in ARCO stage I patients, 71.4% in ARCO stage II patients, and 75.0% in ARCO stage III patients. Imaging success was observed in all stage I hips, 64.3% of stage II hips, and 12.5% of stage III hips. Seventeen hips showed progression of the ARCO stage/substage on imaging examination. Eight hips showed femoral head collapse at the 10-year follow-up. Four hips in ARCO stage III and one hip in ARCO stage II were treated with total hip arthroplasty during the follow-up. Three were performed 1 year after ESWT, one at 2 years, and one at 5 years. Conclusions The results of the current study indicated that ESWT is an effective treatment method for nontraumatic ONFH, resulting in pain relief and function restoration, especially for patients with ARCO stage I–II ONFH. |
| first_indexed | 2024-04-14T01:27:45Z |
| format | Article |
| id | doaj.art-f96952aaca864b579e23298179c1bf67 |
| institution | Directory Open Access Journal |
| issn | 1749-799X |
| language | English |
| last_indexed | 2024-04-14T01:27:45Z |
| publishDate | 2018-02-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Orthopaedic Surgery and Research |
| spelling | doaj.art-f96952aaca864b579e23298179c1bf672022-12-22T02:20:20ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2018-02-011311810.1186/s13018-017-0705-xHigh-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral headKai Xie0Yuanqing Mao1Xinhua Qu2Kerong Dai3Qingwei Jia4Zhenan Zhu5Mengning Yan6Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of MedicineShanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of MedicineShanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of MedicineShanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of MedicineAffiliated Hospital of Taishan Medical UniversityShanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of MedicineShanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of MedicineAbstract Background Nontraumatic osteonecrosis of the femoral head (ONFH) is treated with a series of methods. High-energy extracorporeal shock wave therapy (ESWT) is an option with promising mid-term outcomes. The objective of this study was to determine the long-term outcomes of ESWT for ONFH. Methods Fifty-three hips in 39 consecutive patients were treated with ESWT in our hospital between January 2005 and July 2006. Forty-four hips in 31 patients with stage I–III nontraumatic ONFH, according to the Association Research Circulation Osseous (ARCO) system, were reviewed in the current retrospective study. The visual analog pain scale (VAS), Harris hip score, radiography, and magnetic resonance imaging were used to estimate treatment results. The progression of ONFH was evaluated by imaging examination and clinical outcomes. The results were classified as clinical success (no progression of hip symptoms) and imaging success (no progression of stage or substage on radiography and MRI). Results The mean follow-up duration was 130.6 months (range, 121 to 138 months). The mean VAS decreased from 3.8 before ESWT to 2.2 points at the 10-year follow-up (p < 0.001). The mean Harris hip score improved from 77.4 before ESWT to 86.9 points at the 10-year follow-up. The clinical success rates were 87.5% in ARCO stage I patients, 71.4% in ARCO stage II patients, and 75.0% in ARCO stage III patients. Imaging success was observed in all stage I hips, 64.3% of stage II hips, and 12.5% of stage III hips. Seventeen hips showed progression of the ARCO stage/substage on imaging examination. Eight hips showed femoral head collapse at the 10-year follow-up. Four hips in ARCO stage III and one hip in ARCO stage II were treated with total hip arthroplasty during the follow-up. Three were performed 1 year after ESWT, one at 2 years, and one at 5 years. Conclusions The results of the current study indicated that ESWT is an effective treatment method for nontraumatic ONFH, resulting in pain relief and function restoration, especially for patients with ARCO stage I–II ONFH.http://link.springer.com/article/10.1186/s13018-017-0705-xHigh-energy extracorporeal shock wave therapyOsteonecrosisFemoral headFollow-up studiesBone marrow edema |
| spellingShingle | Kai Xie Yuanqing Mao Xinhua Qu Kerong Dai Qingwei Jia Zhenan Zhu Mengning Yan High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head Journal of Orthopaedic Surgery and Research High-energy extracorporeal shock wave therapy Osteonecrosis Femoral head Follow-up studies Bone marrow edema |
| title | High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head |
| title_full | High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head |
| title_fullStr | High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head |
| title_full_unstemmed | High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head |
| title_short | High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head |
| title_sort | high energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head |
| topic | High-energy extracorporeal shock wave therapy Osteonecrosis Femoral head Follow-up studies Bone marrow edema |
| url | http://link.springer.com/article/10.1186/s13018-017-0705-x |
| work_keys_str_mv | AT kaixie highenergyextracorporealshockwavetherapyfornontraumaticosteonecrosisofthefemoralhead AT yuanqingmao highenergyextracorporealshockwavetherapyfornontraumaticosteonecrosisofthefemoralhead AT xinhuaqu highenergyextracorporealshockwavetherapyfornontraumaticosteonecrosisofthefemoralhead AT kerongdai highenergyextracorporealshockwavetherapyfornontraumaticosteonecrosisofthefemoralhead AT qingweijia highenergyextracorporealshockwavetherapyfornontraumaticosteonecrosisofthefemoralhead AT zhenanzhu highenergyextracorporealshockwavetherapyfornontraumaticosteonecrosisofthefemoralhead AT mengningyan highenergyextracorporealshockwavetherapyfornontraumaticosteonecrosisofthefemoralhead |